SUZHOU, China and ROCKVILLE, Md., Dec. 13, 2023 /PRNewswire/ — Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it has released updated data from a randomized, controlled, registrational Phase II study of the company’s novel drug candidate, olverembatinib (R&D… Continue reading Live from ASH 2023 | Results from Chinese Studies of Olverembatinib Presented in Oral Report at the ASH Annual Meeting for the Sixth Consecutive Year, Including Data Showing Promising Efficacy in Patients with TKI-Resistant and/or Intolerant CML-CP
Category: Newswire
Valmet reaches two significant milestones in its Climate Program
Valmet Oyj’s press release on December 13, 2023 at 10:30 a.m. EET ESPOO, Finland, Dec. 13, 2023 /PRNewswire/ — Valmet’s Climate Program – Forward to a carbon neutral future – was launched in 2021. The program covers the entire value chain and includes four key targets for the supply chain, Valmet’s own operations and the use of… Continue reading Valmet reaches two significant milestones in its Climate Program
Engimmune Therapeutics strikes ‘fast-forward’ micro-fluidics collaboration with Swiss innovator CSEM
Collaboration with CSEM will speed up identification of suitable soluble TCR candidates Engimmune’s executive team will be presenting at Biotech Showcase in San Francisco in January BASEL, Switzerland, Dec. 13, 2023 /PRNewswire/ — Engimmune Therapeutics AG (“Engimmune”), a world-class developer of soluble T-cell receptor drugs (‘TCRs’) to treat solid tumours, is pleased to announce that… Continue reading Engimmune Therapeutics strikes ‘fast-forward’ micro-fluidics collaboration with Swiss innovator CSEM
Biocomposites exceeds revenue expectations and takes a big step forward in its research and development
New record for sales growth and number of patients supported Product portfolio enhanced through acquisition of NanoBone® and expansion of STIMULAN® approval as an antibiotic carrier to treat bacterial infection Research and Development boosts with STIMULAN VG moving to phase II clinical trial and investment in Renovite KEELE, England, Dec. 13, 2023 /PRNewswire/ — Biocomposites, an international… Continue reading Biocomposites exceeds revenue expectations and takes a big step forward in its research and development
Havfram Wind signs contract with RWE for turbine transport and installation support for Nordseecluster offshore wind projects
OSLO, Norway, Dec. 13, 2023 /PRNewswire/ — As anticipated in the preferred supplier agreement announced on April 13th, 2023, Havfram and RWE have signed a contract for the transportation and installation of turbines for RWE’s Nordseecluster projects. The projects combine four wind farm sites in the eastern part of the German North Sea and will… Continue reading Havfram Wind signs contract with RWE for turbine transport and installation support for Nordseecluster offshore wind projects
LG Innotek doubles the size of the open booth at CES 2024
Exhibition booth of 330m2 provided in the entrance of West Hall Mobility and AI related innovative components exhibited including electric autonomous vehicles From robot to UAM… Future scalability ’emphasized’ on the core basic technologies SEOUL, South Korea, Dec. 13, 2023 /PRNewswire/ — LG Innotek (CEO Moon Hyuk-soo) announced on the 13th that innovative products and technologies… Continue reading LG Innotek doubles the size of the open booth at CES 2024
Trike Market to Reach $5,185.37 million, Globally, by 2032 at 7.6% CAGR: Allied Market Research
Rising interest in leisure & recreational trikes and accessibility of trikes to people with locomotor disability drive the growth of the global trike market. PORTLAND, Ore., Dec. 13, 2023 /PRNewswire/ — Allied Market Research published a report, titled, “Trike Market by Propulsion (IC Engine, Electric, and Human Powered), Application (Healthcare, Leisure, and Others), and Type (Reverse and Delta):… Continue reading Trike Market to Reach $5,185.37 million, Globally, by 2032 at 7.6% CAGR: Allied Market Research
Volocopter Wins Over Young Hearts with First Osaka & Hyogo Flight
BRUCHSAL. Germany, Dec. 13, 2023 /PRNewswire/ — Volocopter, the pioneer of urban air mobility (UAM), successfully conducted a multi-day flight test campaign (from 7 to 13 December) with a crewed 2X aircraft in the Japanese cities of Osaka and Amagasaki. This week-long testing campaign signifies the completion of the first steps of local flight testing… Continue reading Volocopter Wins Over Young Hearts with First Osaka & Hyogo Flight
ICONSIAM joins the ‘Thailand Winter Festival’ with “The Vijit Chao Phraya”, a month-long extravaganza of breathtaking riverside light-and-sound shows during December 2023
Chosen as a highlight festival location BANGKOK, Dec. 13, 2023 /PRNewswire/ — ICONSIAM, the Thailand landmark destination located on the Chao Phraya riverside in Bangkok, has been chosen as one of the seven highlight locations for the “The Vijit Chao Phraya 2023” event, a part of ‘Thailand Winter Festival’ of the Tourism Authority of Thailand… Continue reading ICONSIAM joins the ‘Thailand Winter Festival’ with “The Vijit Chao Phraya”, a month-long extravaganza of breathtaking riverside light-and-sound shows during December 2023
The EPIC untold story behind Fairytale of New York
EPIC The Irish Emigration Museum assembles “the boys of the NYPD choir” to sing Galway Bay this Christmas Exhibition launches in Dublin telling the story of The Pogues and Shane MacGowan DUBLIN, Dec. 12, 2023 /PRNewswire/ — The Pogues’ song Fairytale of New York is regarded by many as the anthem for Irish global emigration. It remains… Continue reading The EPIC untold story behind Fairytale of New York